1. Gain-of-Function SAMD9L Mutations Cause a Syndrome of Cytopenia, Immunodeficiency, Myelodysplastic Syndrome and Neurological Symptoms. (April 2017) Authors: Tesi, B.; Davidsson, J.; Voss, M.; Rahikkala, E.; Holmes, T.; Chiang, S.; Komulainen-Ebrahim, J.; Kokkonen, H.; Bryder, D.; Fioretos, T.; Henter, J.I.; Möttönen, M.; Niinimäki, R.; Nilsson, L.; Pronk, C.J.; Uusimaa, J.; Moilanen, J.; Tedgård, U.; Cammenga, J.; Bryceson, Y. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B. (23rd June 2022) Authors: Tobiasson, M.; Pandzic, T.; Illman, J.; Nilsson, L.; Weström, S.; Sollander, K.; Ejerblad, E.; Olsnes Kittang, A.; Olesen, G.; Werlenius, O.; Björklund, A.; Wiggh, J.; lindholm, C.; Lorentz, F.; Rasmussen, B.; Cammenga, J.; Weber, D.; Grönnås, D.; Dimitriou, M.; Kytölä, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS. (May 2023) Authors: Lindholm, C.; Tobiasson, M.; Pandzic, T.; Illman, J.; Nilsson, L.; Weström, S.; Ejerblad, E.; Olesen, G.; Björklund, A.; Kittang, A. Olsnes; Werlenius, O.; Wiggh, J.; Lorentz, F.; Rasmussen, B.; Cammenga, J.; Weber, D.; Moen, A.E.; Lundström, L.Y.; Bahr, L. Von; Dimitriou, M. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗